Cargando…
On improvement in ejection fraction with iron chelation in thalassemia major and the risk of future heart failure
BACKGROUND: Trials of iron chelator regimens have increased the treatment options for cardiac siderosis in beta-thalassemia major (TM) patients. Treatment effects with improved left ventricular (LV) ejection fraction (EF) have been observed in patients without overt heart failure, but it is unclear...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180261/ https://www.ncbi.nlm.nih.gov/pubmed/21910880 http://dx.doi.org/10.1186/1532-429X-13-45 |